156 related articles for article (PubMed ID: 26918831)
1. Anti-cancer drug 3,3'-diindolylmethane activates Wnt4 signaling to enhance gastric cancer cell stemness and tumorigenesis.
Zhu Y; Zhang B; Gong A; Fu H; Zhang X; Shi H; Sun Y; Wu L; Pan Z; Mao F; Zhu W; Qian H; Xu W
Oncotarget; 2016 Mar; 7(13):16311-24. PubMed ID: 26918831
[TBL] [Abstract][Full Text] [Related]
2. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.
Li XJ; Park ES; Park MH; Kim SM
Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339
[TBL] [Abstract][Full Text] [Related]
3. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
Jin H; Park MH; Kim SM
Oncol Rep; 2015 Apr; 33(4):2031-6. PubMed ID: 25633416
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
[TBL] [Abstract][Full Text] [Related]
5. 3,3'-diindolylmethane exerts antiproliferation and apoptosis induction by TRAF2-p38 axis in gastric cancer.
Ye Y; Ye F; Li X; Yang Q; Zhou J; Xu W; Aschner M; Lu R; Miao S
Anticancer Drugs; 2021 Feb; 32(2):189-202. PubMed ID: 33315588
[TBL] [Abstract][Full Text] [Related]
6. 3,3'-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy.
Ye Y; Fang Y; Xu W; Wang Q; Zhou J; Lu R
Biochem Pharmacol; 2016 Sep; 115():77-84. PubMed ID: 27372603
[TBL] [Abstract][Full Text] [Related]
7. WNT4 mediates the autocrine effects of growth hormone in mammary carcinoma cells.
Vouyovitch CM; Perry JK; Liu DX; Bezin L; Vilain E; Diaz JJ; Lobie PE; Mertani HC
Endocr Relat Cancer; 2016 Jul; 23(7):571-85. PubMed ID: 27323961
[TBL] [Abstract][Full Text] [Related]
8. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
9. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Zou M; Zhang X; Xu C
Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
[TBL] [Abstract][Full Text] [Related]
10. SALL4, a novel marker for human gastric carcinogenesis and metastasis.
Zhang L; Xu Z; Xu X; Zhang B; Wu H; Wang M; Zhang X; Yang T; Cai J; Yan Y; Mao F; Zhu W; Shao Q; Qian H; Xu W
Oncogene; 2014 Nov; 33(48):5491-500. PubMed ID: 24276240
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells.
Jin Y; Zou X; Feng X
Anticancer Drugs; 2010 Oct; 21(9):814-22. PubMed ID: 20724916
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.
Zhu J; Li Y; Guan C; Chen Z
Oncol Rep; 2012 Sep; 28(3):1063-8. PubMed ID: 22736073
[TBL] [Abstract][Full Text] [Related]
13. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer.
Lu J; Li G; He K; Jiang W; Xu C; Li Z; Wang H; Wang W; Wang H; Teng X; Teng L
J Transl Med; 2015 Feb; 13():42. PubMed ID: 25638174
[TBL] [Abstract][Full Text] [Related]
14. 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice.
Chang X; Tou JC; Hong C; Kim HA; Riby JE; Firestone GL; Bjeldanes LF
Carcinogenesis; 2005 Apr; 26(4):771-8. PubMed ID: 15661811
[TBL] [Abstract][Full Text] [Related]
15. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
[TBL] [Abstract][Full Text] [Related]
16. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
18. WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα.
Qian Z; Lin W; Cai X; Wu J; Ke K; Ye Z; Wu F
Cancer Biol Ther; 2024 Dec; 25(1):2299288. PubMed ID: 38178596
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide transcriptome analysis reveals inactivation of Wnt/β-catenin by 3,3'-diindolylmethane inhibiting proliferation of colon cancer cells.
Leem SH; Li XJ; Park MH; Park BH; Kim SM
Int J Oncol; 2015 Sep; 47(3):918-26. PubMed ID: 26203047
[TBL] [Abstract][Full Text] [Related]
20. 3,3'-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing.
Shi H; Xu X; Zhang B; Xu J; Pan Z; Gong A; Zhang X; Li R; Sun Y; Yan Y; Mao F; Qian H; Xu W
Theranostics; 2017; 7(6):1674-1688. PubMed ID: 28529644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
